Sciety

Sciety is a prominent investment syndicate specializing in the life science sector across the Nordic region, headquartered in Stockholm, Sweden. The firm serves as a crucial bridge, connecting a vast network of private investors, family offices, and institutions with promising unlisted life science companies. Their unique model streamlines the investment process, making it more efficient for both investors seeking opportunities and companies in need of capital.

Sciety's primary focus is on early-stage to growth-stage companies, encompassing a broad spectrum of the life science industry, including biotechnology, pharmaceuticals, medical technology, and diagnostics. They frequently take on the role of a lead or co-investor, leveraging their extensive network to facilitate significant funding rounds. Since its inception in 2018, Sciety has demonstrated substantial impact, having successfully assisted more than 30 companies in raising over SEK 1.3 billion (approximately $123.5 million USD) in capital.

The strength of Sciety lies in its robust investor network, which comprises more than 8,000 registered members. This collective power enables them to mobilize substantial capital for their portfolio companies. They typically facilitate investment rounds ranging from SEK 10 million to SEK 100 million (approximately $0.95 million to $9.5 million USD), providing not only financial backing but also strategic expertise and access to a valuable network for growth. Sciety's model is designed to accelerate innovation within the Nordic life science ecosystem by ensuring that high-potential companies receive the necessary resources to develop and commercialize their breakthroughs.